MR IMAGING IN THE MODE OF DIFFUSION-WEIGHTED IMAGES OF THE WHOLE BODY (MR-DWI-WB) IN THE DIAGNOSIS OF COMMON LUNG CANCER (LITERATURE REVIEW)
PDF (Русский)

Keywords

WHOLE BODY MAGNETIC-RESONANCE DIFFUSION IMAGING IS THE USEFUL METHOD FOR TUMOR DETECTION
TUMOR CHARACTERIZATION AND THERAPY MONITORING

How to Cite

Kobyakova, Y., Dolgushin, M., Davydov, M., & Nazliev, P. (2018). MR IMAGING IN THE MODE OF DIFFUSION-WEIGHTED IMAGES OF THE WHOLE BODY (MR-DWI-WB) IN THE DIAGNOSIS OF COMMON LUNG CANCER (LITERATURE REVIEW). Voprosy Onkologii, 64(6), 722–731. https://doi.org/10.37469/0507-3758-2018-64-6-722-731

Abstract

Whole body magnetic-resonance diffusion imaging (whole body MR-DWI) is the useful method for tumor detection, tumor characterization and therapy monitoring. The method if combined with its modern availability of MRI scanners has a wide spectrum of clinical impact in oncology. Current review is focused on the use of whole body MR-DWI in disseminated lung cancer that is one of the most common malignancies. General technical aspects of the method are presented and usefulness of WB MR-DWI in primary diagnostic of intra-thoracic nodules, tumor dissemination, TNM-staging and therapy monitoring in lung cancer patients also. Lack of standardization of measurement parameters limits the comparability of current research results. However due to cheap price and diagnostic opportunity of the method it can successfully compete with PET/CT in primary diagnostic and treatment monitoring in disseminated lung cancer.
https://doi.org/10.37469/0507-3758-2018-64-6-722-731
PDF (Русский)

References

Давыдов М.И., Ганцев Ш.Х. Онкология: учебник. - Москва. «ГЭОТАР-Медиа», 2010. - 920 с.

Долгушин М.Б., Фадеева Л.М., Зайцев А.Ю. и др. 3D-диффузионно-взвешенная магнитно-резонансная томография всего тела у пациентов с метастатическим поражением головного мозга // Медицинская визуализация. - 2008. - Т. 1. - С. 118-123.

Горбунова В.А., Артамонова Е.В., Бредер В.В. и др. Практические рекомендации по лекарственному лечению немелкоклеточного рака легкого // Злокачественные опухоли. -2016. - № 4. Спецвыпуск 2. - С. 22-33. - DOI: 10.18027/2224-5057-2016-4s2-22-33

Горбунова В.А., Пигарова Е.А., Рожинская Л.Я. и др. Применение сорафениба (нексовара) в лечении больной диссеминированным раком паращитовидных желез (клинический случай) // Опухоли головы и шеи. - 2016. - Т. 6(4). - С. 67-72. - DOI: 10.17650/2222-1468-2016-6-4-67-72

Карташов М.В., Карташова П.М., Котляров П.М. Первый опыт применения диффузионно-взвешенной магнитно-резонансной томографии при мелкоклеточном раке легкого // Медицинская визуализация. - 2011. - № 4. - С. 28-33.

Корниенко В.Н., Пронин И.Н., Голанов А.В. и. др. Диффузионно-взвешенные изображения в диагностике глиом головного мозга // Медицинская визуализация. - 2000. - С. 18-25.

Корниенко В.Н., Пронин И.Н. Диагностическая нейрорадиология // Москва. - 2008-2012. - 1852 с.

Серков С.В., Пронин И.Н., Фадеева Л.М. и др. Диффузионно-взвешенная МРТ в диагностике объемных образований задней черепной ямки // Медицинская визуализация. - 2004. - № 2. - С. 66-75.

Abdel Razek A., Fathy A., Abdel Gawad T. Correlation of apparent diffusion coefficient value with prognostic parameters of lung cancer // J. Comput. Assist Tomogr. - 2011. - Vol. 35. - P 248-252. - DOI: 10.1097/RCT.0b013e31820ccf73

Antoch G., Bockisch A. Combined PET/MRI: a new dimension in whole-body oncology imaging? // Eur. J. Nucl. Med. Mol. Imaging. - 2009. - Vol. 36(suppl 1). - P. S113-S120.

Antoch G., Vogt F.M., Freudenberg L.S. et al. Whole-body dual-modality PET/CT and whole-body MRI for tumor staging in oncology // JAMA. - 2003. - Vol. 290. - P. 3199-3206.

Blomqvist L., Torkzad M.R. Whole-body imaging with MRI or PET/CT: the future for single-modality imaging in oncology? // JAMA. - 2003. - Vol. 290. - P. 3248 -3249.

Cha S. Update on brain tumor imaging: from anatomy to physiology // AJNR Am J. Neuroradiol. - 2006. - Vol. 27(3). - P 475-487.

Cheran S.K., Herndon J.E. 2nd, Patz E.F. Jr. Comparison of whole-body FDG-PET to bone scan for detection of bone metastases In patients with a new diagnosis of Lung Cancer // Lung Cancer. - 2004. - Vol. 44(3). - P. 317 -325.

Chin A.Y, Kyung S.L., Lee H.Y et al. Coregistered Whole Body Magnetic Resonance Imaging-Positron Emission Tomography (MRI-PET) Versus PET-Computed Tomography Plus Brain MRI in Staging Resectable Lung Cancer // Comparisons of Clinical Effectiveness in a Randomized Trial. - 2013. - P. 1784-1791.

Curvo-Semedo L., Lambregts D.M., Maas M., Beets G.L. et al. Diffusion-weighted MRI in rectal cancer: apparent diffusion coefficient as a potential noninvasive marker of tumor aggressiveness // J. Magn. Reson. Imaging. - 2012. - Vol. 35. - P. 1365-1371.

Duygulu G., Ovali G.Y, Calli C. et al. Intracerebral metastasis showing restricted diffusion: correlation with histopathologic findings // Eur. J. Radiol. - 2010. - Vol. 74(1). - P. 117-120.

Chen G.X., Wang M.H. et al. Diffusion-weighted magnetic resonance imaging for the detection of metastatic lymph nodes in patients with lung cancer: A meta-analysis // Mol Clin Oncol. - 2017. - Vol. 6(3). - P. 44-354. - DOI: 10.3892/mco.2017.1153

Hamstra DA, Rehemtulla A, Ross BD. Diffusion magnetic resonance imaging: a biomarker for treatment response in oncology // J. Clin. Oncol. - 2007. - Vol. 25(26). - P. 4104-4109.

Hasegawa I., Boiselle P., Kuwabara K. et al. Mediastinal lymph nodes in patients with non-small cell lung cancer: preliminary experience with diffusion-weighted MR imaging // J. Thorac. Imaging. - 2008. - Vol. 23. - P. 157161. - DOI: 10.1097/RTI.0b013e318166d2f5

Hayashida Y, Hirai T., Morishita S. et al. Diffusion-weighted imaging of metastatic brain tumors: comparison with histologic type and tumor cellularity // AJNR Am. J. Neuroradiol. - 2006. - Vol. 27(7). - P. 1419-1425.

Henzler T., Schmid-Bindert G., Schoenberg S.O., Fink C. Diffusion and perfusion MRI of the lung and mediastinum // Eur. J. Radiol. - 2010. - Vol. 76. - P. 329336. - PMid:20627435. DOI: 10.1016/j.ejrad.2010.05.005

Heusner T.A., Kuemmel S., Koeninger A. et al. Diagnostic value of diffusion-weighted magnetic resonance imaging (DWI) compared to FDG PET/CT for whole-body breast cancer staging // Eur. J. Nucl. Med. Mol. Imaging. - 2010. - Vol. 37. - P. 1077-1086.

Heusner T.A., Kuemmel S., Koeninger A. et al. Diagnostic value of diffusion-weighted magnetic resonance imaging (DWI) compared to FDG PET/CT for whole-body breast cancer staging // Eur. J. Nucl. Med. Mol. Imaging. - 2010. - Vol. 37(6). - P. 1077-1086. - 10.1007/ s00259-010-1399-z. PMID: 20204355. DOI: 10.1007/s00259-010-1399-z

Iima M., Reynaud O., Tsurugizawa T. et al. Characterization of Glioma Microcirculation and Tissue Features Using Intravoxel Incoherent Motion Magnetic Resonance Imaging in a Rat Brain Model // Invest. Radiol. - 2014. - Vol. 49(7). - P 485-490.

Kanauchi N., Oizumi H., Honma T. et al. Role of diffusionweighted magnetic resonance imaging for predicting of tumor invasiveness for clinical stage IA nonsmall cell lung cancer // Eur. J. Cardiothorac. Surg. - 2009. - Vol. 35. - P. 706-711. - 10.1016:j.ejcts.2008.12.039. DOI: 10.1016/j.ejcts.2008.12.039

Koh D.M., Collins D.J. Diffusion-weighted MRI in the body: applicationsand challenges in oncology // Am. J. Roentgenol. - 2007. - Vol. 188. - P. 1622-1635.

Kwee T.C., Takahara T., Ochiai R. et al. Whole-body diffusion-weighted magnetic resonance imaging // Eur. J. Radiol. - 2009. - Vol. 70(3). - P 409-417. - DOI: 10.1016/j.ejrad.2009.03.054

Lauenstein T.C., Goehde S.C., Herborn C.U. et al. Whole-body MR imaging: evaluation of patients for metastases // Radiology. - 2004. - Vol. 233. - P. 139-148.

Le Bihan D. Molecular diffusion nuclear magnetic resonance imaging // Magn Reson Q. - 1991. - Vol. 7(1). - P. 1-30.

Le Bihan D. Diffusion, perfusion and functional magnetic resonance imaging // J. Mal. Vasc. - 1995. - Vol. 20(3). - P. 203-214.

Lee M.H., Kim S.R., Park S.Y et al. Application of whole-body MRI to detect the recurrence of lung cancer // Magn Reson Imaging. - 2012. - Vol. 30(10). - P 14391445. - DOI: 10.1016/j.mri.2012.04.014

Liu H., Liu Y, Yu T., Ye N. Usefulness of diffusion-weighted MR imaging in the evaluation of pulmonary lesions // Eur. Radiol. - 2010. - Vol. 20. - P. 807-815. - PMid:19862533. DOI: 10.1007/s00330-009-1629-6

Luna B., Velanova K., Geier C.F. Methodological approaches in developmental neuroimaging studies // Hum. Brain. Mapp. - 2010. - Vol. 31(6). - P. 863871. - DOI: 10.1002/hbm.21073

NCCN. NCCN Clinical Practice Guidelines in Oncology. Non-Small Cell Lung Cancer Version 7. 2015.2015.

Mori T., Nomori H., Ikeda K. et al. Diffusion-weighted magnetic resonance imaging for diagnosing malignant pulmonary nodules/masses // Comparison with positron emission tomography // J. Thorac. Oncol. - 2008. - Vol. 3. - P 358-364. - DOI: 10.1097/JTO.0b013e318168d9ed

Nomori H., Mori T., Ikeda K. et al. Diffusion-weighted magnetic resonance imaging can be used in place of positron emission tomography for N staging of nonsmall cell lung cancer with fewer false-positive results // J. Thorac. Cardiovasc. Surg. - 2008. - Vol. 135. - P. 816-822. - DOI: 10.1016/j.jtcvs.2007.10.035

Ohba Y, Nomori H., Mori T. et al. Is diffusion-weighted magnetic resonance imaging superior to positron emission tomography with fludeoxyglucose F 18 in imaging nonsmall cell lung cancer? // J. Thorac. Cardiovasc. Surg. - 2009. - Vol. 138. - P. 439-445. - DOI: 10.1016/j.jtcvs.2008.12.026

Ohno Y, Koyama H., Yoshikawa T. et al. N stage disease in patients with non-small cell lung cancer: efficacy of quantitative and qualitative assessment with STIR turbo spin-echo imaging, diffusion-weighted MR imaging, and fluorodeoxyglucose PET/ CT // Radiology. - 2011. - Vol. 261. - P 605-615. - DOI: 10.1148/radiol.11110281

Ohno Y, Koyama H., Onishi Y et al. Non small cell lung cancer: whole-body MR examination for M-stage assessment - utility for whole-body diffusion-weighted imaging compared with integrated FDG PET/CT // Radiology. - 2008. - Vol. 248. - P. 643-654. - DOI: 10.1148/radiol.2482072039

Okuma T., Matsuoka T., Yamamoto A. et al. Assessment of early treatment response after CT-guided radiofrequency ablation of unresectable lung tumours by diffusion-weighted MRI: a pilot study // Br. J. Radiol. - 2009. - Vol. 82. - P 989-994. - DOI: 10.1259/bjr/13217618

Ohno Y, Nishio M., Koyama H. et al. Comparison of the utility of whole-body MRI with and without contrast-enhanced Quick 3D and double RF fat suppression techniques, conventional whole-body MRI, PET/CT and conventional examination for assessment of recurrence in NSCLC patients // Eur. J. Radiol. - 2013. - Vol. 82(11). - P 2018-2027. - DOI: 10.1016/j.ejrad.2013.07.016

Padhani A. Whole-Body Diffusion-weighted MR Imaging in Canser: Current Status and Research Directions // Radiology. - 2011. - Vol. 261. - № 3.

Porto L., Jurcoane A., Schwabe D., Kieslich M, Hattingen E. Differentiation between high and low grade tumours in paediatric patients by using apparent diffusion coefficients // Eur. J. Paediatr. Neurol. - 2013. - Vol. 17(3). - P 302-307.

Razek A.A. Diffusion magnetic resonance imaging of chest tumors // Review. Cancer Imaging. - 2012. - Vol. 12. - P. 452-463. - DOI: 10.1102/1470-7330.2012.0041

Regier M., Schwarz D., Henes F. et al. Diffusion-weighted MRimaging for the detection of pulmonary nodules at 1.5 Tesla: intraindividual comparison with multidetector computed tomography // J. Med. Imaging Radiat. Oncol. - 2011. - Vol. 55. - P. 266-274. - DOI: 10.1111/j.1754-9485.2011.02263.x

Regier M., Schwarz D., Henes F. et al. Diffusion-weighted MRimaging for the detection of pulmonary nodules at 1.5 Teslaxintraindividual comparison with multidetector computed tomography // J. Med. Imaging Radiat. Oncol. - 2011. - Vol. 55. - P. 266-274. - DOI: 10.1111/j.1754-9485.2011.02263.x

Satoh S., Kitazume Y, Ohdama S. et al. Can malignant and benign pulmonary nodules be differentiated with diffusion-weighted MRI? // Am J. Roentgenol. - 2008. - Vol. 191. - P. 464-470. - DOI: 10.2214/AJR.07.3133

Shim S.S., Lee K.S., Kim B.T. et al. Non-small cell lung cancer: prospective comparison of integrated FDG PET/ CT and CT alone for preoperative staging // Radiology. - 2005. - Vol. 236(3). - P. 1011-1019.

Sommer G., Wiese M., Winter L. et al. Preoperative staging of non-small-cell lung cancer: comparison of whole-body diffusion-weighted magnetic resonance imaging and 18F-fluorodeoxyglucose-positron emission tomography/ computed tomography // Eur. Radiol. - 2012. - Vol. 22(12). - P 2859-2867. - DOI: 10.1007/s00330-012-2542-y

Takahara T., Imai Y., Yamashita T. et al. Diffusion weighted whole body imaging with background body signal suppression (DWIBS): technical improvement using free breathing, STIR and high resolution 3D display // Radiat. Med. - 2004. - Vol. 22. - P. 275-282.

Takenaka D., Ohno Y., Matsumoto K. et al. Detection of bone metastases in non-small cell lung cancer patients: comparison of whole-body diffusion-weighted imaging (DWI), whole-body MR imaging without and with DWI, whole-body FDGPET/CT, and bone scintigraphy // J. Magn. Reson. Imaging. - 2009. - Vol. 30. - P. 298308. - DOI: 10.1002/jmri.21858

Tondo F., Saponaro A., Stecco A. et al. Role of diffusion-weighted imaging in the differential diagnosis of benign and malignant lesions of the chest-mediastinum // Radiol. Med. - 2011. - Vol. 116. - P. 720-733. - DOI: 10.1007/s11547-011-0629-1

Turner R., Le Bihan D., Maier J., Vavrek R. et al. Echo-planar imaging of intravoxel incoherent motion // Radiology. - 1990. - Vol. 177(2). - P. 407-414.

Wilhelm T., Stieltjes B., Schlemmer H.P. Whole-Body-MR-Diffusion Weighted Imaging // Fortschr R ntgenstr. - 2013. - Vol. 185. - P. 950-958.

Wilhelm T., Stieltjes B., Schlemmer H.P. WholeBody-MR-Diffusion Weighted Imaging in oncology // Fortschr. R ntgenstr. - 2013. - Vol. 185. - P. 950-958.

Wong F.C., Kim E.E. A review of molecular imaging studies reaching the clinical stage // Eur. J. Radiol. - 2009. - Vol. 70(2). - P. 205-211. - DOI: 10.1016/j.ejrad.2009.01.049

Yabuuchi H., Hatakenaka M., Takayama K. et al. Nonsmall cell lung cancer: detection of early response to chemotherapy by using contrast-enhanced dynamic and diffusion-weighted MR imaging // Radiology. - 2011. - Vol. 261. - P. 598-604. - DOI: 10.1148/radiol.11101503

Zakaria R., Das K., Radon M. et al. Diffusion-weighted MRI characteristics of the cerebral metastasis to brain boundary predicts patient outcomes // BMC Med Imaging. - 2014. - № 3. - DOI: 10.1186/1471-2342-14-26

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

© АННМО «Вопросы онкологии», Copyright (c) 2018